Fig. 2From: Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysisForest plot for the meta-analysis of TIMI grade 3 blood flow achievement in patients assigned to prasugrel or ticagrelor as compared with clopidogrel on the basis of GPIBack to article page